Dynamic Modulation of Microglia/Macrophage Polarization by miR-124 after Focal Cerebral Ischemia

Somayyeh Hamzei Taj1, Widuri Kho1, Markus Aswendt1

  • 1In-vivo-NMR Laboratory, Max Planck Institute for Metabolism Research, Gleuelerstrasse 50, D-50931, Köln, Germany.

Insights

MicroRNA-124 (miR-124) therapy during the sub-acute phase of ischemic stroke reduces detrimental inflammation. Early miR-124 administration promotes neurological recovery by shifting immune cell polarization.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Mononuclear phagocytes, including microglia/macrophages, exhibit dynamic polarization in ischemic stroke, transitioning from protective to detrimental phenotypes.
  • Microglia/macrophages play dual roles in stroke, necessitating precise modulation of their inflammatory state rather than broad suppression.
  • MicroRNA-124 (miR-124), a brain-specific microRNA, influences neuronal differentiation and microglia quiescence.

Purpose of the Study:

  • To investigate the therapeutic potential of intracerebral miR-124 administration in a mouse model of ischemic stroke.
  • To determine if miR-124 injection timing (before or after the pro-inflammatory peak) affects immune cell polarization and neurological recovery.

Main Methods:

  • Ischemic stroke induced in a mouse model.
  • Intracerebral injection of liposomated miR-124 at different time points post-stroke (sub-acute vs. later phase).
  • Assessment of microglia/macrophage polarization (pro-inflammatory vs. anti-inflammatory balance) and neurological deficit evaluation.

Main Results:

  • Liposomated miR-124 administered 48 hours after stroke shifted microglia/macrophages towards an anti-inflammatory phenotype.
  • This shift in immune response led to improved neurological deficit by day 6 post-stroke.
  • Delayed miR-124 injection (10 days post-stroke) showed a lesser reduction in the pro-/anti-inflammatory ratio and no significant effect on recovery at day 14.

Conclusions:

  • miR-124 administration is most effective when given before the peak of the pro-inflammatory response in the sub-acute phase of ischemic stroke.
  • Modulating the polarization balance of immune cells, particularly microglia/macrophages, holds therapeutic relevance for stroke rehabilitation.
  • Targeting immune cell polarization with miR-124 offers a promising strategy to enhance recovery opportunities in the sub-acute phase of stroke.

Related Concept Videos